Educational Symposium
Diagnosis and Treatment of Hypocalcemia, Hypercalciuria, Nephrocalcinosis, and Kidney Stones
October 24, 2026 | 12:45 PM - 01:45 PM
Location: Centennial Ballroom F, Hyatt Regency Denver
Session Description
Hypocalcemia has both genetic and acquired causes. This symposium focuses on genetic and acquired causes of hypoparathyroidism, including autosomal dominant hypocalcemia type 1 (ADH1), an underrecognized genetic condition. Experts review the pathophysiology of hypocalcemia and its complications and discuss common standard-of-care approaches, their risks, and strategies to minimize unintended treatment-related effects, such as nephrolithiasis and nephrocalcinosis.
Doors open around 12:30 p.m. Seating is limited and available on a first-come, first-served basis to fully paid Annual Meeting participants. When a room reaches capacity, ASN will close the room, and no other participants will be allowed to enter, regardless of how many exit.
Support is provided by an educational grant from BridgeBio Pharma, Inc.
Learning Objective(s)
- Describe the causes of hypocalcemia
- List the treatment strategies for acquired and genetic causes of hypoparathyroidism
- Compare the benefits and risks of standard and novel treatment strategies for hypoparathyroidism
Learning Pathway(s)
- Bones‚ Stones‚ and Mineral Metabolism
- CKD Non-Dialysis
Moderator
Presentations
- Introduction
12:45 PM - 12:55 PM
- Genetic Causes of Hypercalciuria, Nephrolithiasis, and Nephrocalcinosis
12:55 PM - 01:15 PM
- Pathophysiology of Hypocalcemia and Treatment Strategies
01:15 PM - 01:35 PM
- Q&A
01:35 PM - 01:45 PM